Speckle Plethysmography Pulse Transit Time as a Marker of Blood Pressure Changes
2 other identifiers
observational
40
1 country
1
Brief Summary
Background: Blood pressure is one of the key markers of cardiovascular health. High blood pressure, also called hypertension, can increase the risk of heart disease or stroke. Monitoring a person s blood pressure continuously over a 24-hour period at home is the best way to diagnose hypertension, but the equipment currently used to do it is cumbersome. This natural history study will test a new technique for monitoring blood pressure continuously over time. Objective: To test a new technique (speckle plethysmography) for measuring blood pressure in healthy adults. Eligibility: Healthy people aged 18 years and older. Design: Participants will come to the clinic a minimum of 2 times. The screening visit will last up to 2 hours. Participants will have a physical exam. Their vital signs will be taken. The clinical visit will last up to 1 hour. Participants will recline in a chair. Sensors to measure the activity of the heart will be placed on their chest. Different sensors will be placed on two fingers and one big toe. A device to measure blood pressure will be placed on one arm. While wearing the sensors, participants will undergo 3 tests: They will be asked to breathe slowly for 2 minutes. They will be asked to solve a math problem. They will immerse one hand or foot into an ice bath for up to 2 minutes. Each test will be followed by a 5-minute recovery period. Participants may elect to return for up to 3 more visits during the following week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2022
CompletedFirst Posted
Study publicly available on registry
September 26, 2022
CompletedStudy Start
First participant enrolled
April 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 8, 2025
CompletedFebruary 27, 2026
February 24, 2026
2.3 years
September 22, 2022
February 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Use of sPTT as a marker for blood pressure.
To examine the use of sPTT as a marker for blood pressure.
1 year
Secondary Outcomes (1)
use of sPTT in comparison to pPTT
1 year
Study Arms (1)
1
Male or female, aged 18 or greater in good general health as evidenced by medical history
Eligibility Criteria
Male or female, aged 18 or greater in good general health as evidenced by medical history
You may qualify if:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Male or female, aged 18 or greater.
- In good general health as evidenced by medical history and physical.
You may not qualify if:
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Any active cardiovascular or pulmonary disorders or use of vasoactive medications.
- History of aneurysm or stroke.
- Pregnant by history.
- History of fainting or seizures.
- An open cut, sore, or bone fracture on or near the hands or feet.
- Known retinopathy, intraocular lens implantation, or glaucoma.
- Any other condition that in the opinion of the investigator would place the participant at unacceptable risk.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Bruce J Tromberg
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 22, 2022
First Posted
September 26, 2022
Study Start
April 19, 2023
Primary Completion
August 5, 2025
Study Completion
August 8, 2025
Last Updated
February 27, 2026
Record last verified: 2026-02-24